Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

COLCHICINE has been shown to inhibit deoxyribonuclease and de-phosphorylation and de-amination of deoxyribonucleotides 1. The beneficial effect of colchicine in gout is possibly due to the effect ...

WASHINGTON, DC—The routine use of colchicine, an anti-inflammatory agent with a challenging side-effect profile, fails to reduce the risk of major adverse cardiovascular events when used in patients ...

Colchicine-binding site inhibitors present good selectivity and minor acquired multidrug resistance and toxicity effects compared to antitubulin drugs, such as docetaxel, paclitaxel, vincristine or ...

WASHINGTON, DC – OCTOBER 29, 2024 – The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce ...